2016-08-17 |
2016-08-16 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
1,561
-0.4%
6.42
10,024
USD
|
1,561
-0.4%
|
6.42
|
10,024
USD
|
|
2016-08-17 |
2016-08-16 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
37,481
-3.3%
6.29
235,834
USD
|
37,481
-3.3%
|
6.29
|
235,834
USD
|
|
2016-08-17 |
2016-08-16 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
4,674
-0.4%
6.42
30,013
USD
|
4,674
-0.4%
|
6.42
|
30,013
USD
|
|
2016-08-17 |
2016-08-16 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
50,000
-3.1%
6.29
314,605
USD
|
50,000
-3.1%
|
6.29
|
314,605
USD
|
|
2016-08-17 |
2016-08-16 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
6,235
-0.4%
6.42
40,037
USD
|
6,235
-0.4%
|
6.42
|
40,037
USD
|
|
2016-08-17 |
2016-08-16 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
50,000
-3.1%
6.29
314,605
USD
|
50,000
-3.1%
|
6.29
|
314,605
USD
|
|
2016-08-17 |
2016-08-16 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
6,235
-0.4%
6.42
40,037
USD
|
6,235
-0.4%
|
6.42
|
40,037
USD
|
|
2016-08-17 |
2016-08-15 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
10,958
-2.8%
6.45
70,660
USD
|
10,958
-2.8%
|
6.45
|
70,660
USD
|
|
2016-08-17 |
2016-08-15 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
32,807
-2.8%
6.45
211,549
USD
|
32,807
-2.8%
|
6.45
|
211,549
USD
|
|
2016-08-17 |
2016-08-15 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
43,765
-2.6%
6.45
282,210
USD
|
43,765
-2.6%
|
6.45
|
282,210
USD
|
|
2016-08-17 |
2016-08-15 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
43,765
-2.6%
6.45
282,210
USD
|
43,765
-2.6%
|
6.45
|
282,210
USD
|
|
2016-08-17 |
2016-07-25 |
S
Sale
|
Hamilton John Vincent
VP, Regulatory and Clinical
Officer
|
71
-1.2%
6.80
483
USD
|
71
-1.2%
|
6.80
|
483
USD
|
|
2016-08-17 |
2016-07-25 |
S
Sale
|
Gricci Jodi
VP Global Marketing & Training
Officer
|
71
-1.2%
6.80
483
USD
|
71
-1.2%
|
6.80
|
483
USD
|
|
2016-06-06 |
2016-06-03 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
5,289
-0.3%
7.90
41,762
USD
|
5,289
-0.3%
|
7.90
|
41,762
USD
|
|
2016-06-06 |
2016-06-03 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
3,965
-0.3%
7.90
31,308
USD
|
3,965
-0.3%
|
7.90
|
31,308
USD
|
|
2016-06-06 |
2016-06-03 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
1,324
-0.3%
7.90
10,454
USD
|
1,324
-0.3%
|
7.90
|
10,454
USD
|
|
2016-06-06 |
2016-06-03 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
5,289
-0.3%
7.90
41,762
USD
|
5,289
-0.3%
|
7.90
|
41,762
USD
|
|
2016-06-06 |
2016-06-02 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
13,771
-0.8%
7.89
108,668
USD
|
13,771
-0.8%
|
7.89
|
108,668
USD
|
|
2016-06-06 |
2016-06-02 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
10,323
-0.9%
7.89
81,460
USD
|
10,323
-0.9%
|
7.89
|
81,460
USD
|
|
2016-06-06 |
2016-06-02 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
3,448
-0.9%
7.89
27,209
USD
|
3,448
-0.9%
|
7.89
|
27,209
USD
|
|
2016-06-06 |
2016-06-02 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
13,771
-0.8%
7.89
108,668
USD
|
13,771
-0.8%
|
7.89
|
108,668
USD
|
|
2016-06-02 |
2016-06-01 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
1,570
-0.4%
7.58
11,899
USD
|
1,570
-0.4%
|
7.58
|
11,899
USD
|
|
2016-06-02 |
2016-06-01 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
6,270
-0.4%
7.58
47,519
USD
|
6,270
-0.4%
|
7.58
|
47,519
USD
|
|
2016-06-02 |
2016-06-01 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
6,270
-0.4%
7.58
47,519
USD
|
6,270
-0.4%
|
7.58
|
47,519
USD
|
|
2016-06-02 |
2016-06-01 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
4,700
-0.4%
7.58
35,620
USD
|
4,700
-0.4%
|
7.58
|
35,620
USD
|
|
2016-06-02 |
2016-05-31 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
1,277
-0.3%
7.94
10,141
USD
|
1,277
-0.3%
|
7.94
|
10,141
USD
|
|
2016-06-02 |
2016-05-31 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
5,100
-0.3%
7.94
40,499
USD
|
5,100
-0.3%
|
7.94
|
40,499
USD
|
|
2016-06-02 |
2016-05-31 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
5,100
-0.3%
7.94
40,499
USD
|
5,100
-0.3%
|
7.94
|
40,499
USD
|
|
2016-06-02 |
2016-05-31 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
3,823
-0.3%
7.94
30,358
USD
|
3,823
-0.3%
|
7.94
|
30,358
USD
|
|
2016-05-27 |
2016-05-26 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
3,756
-0.9%
8.61
32,328
USD
|
3,756
-0.9%
|
8.61
|
32,328
USD
|
|
2016-05-27 |
2016-05-26 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
11,244
-0.9%
8.61
96,778
USD
|
11,244
-0.9%
|
8.61
|
96,778
USD
|
|
2016-05-27 |
2016-05-26 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
15,000
-0.9%
8.61
129,107
USD
|
15,000
-0.9%
|
8.61
|
129,107
USD
|
|
2016-05-27 |
2016-05-26 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
15,000
-0.9%
8.61
129,107
USD
|
15,000
-0.9%
|
8.61
|
129,107
USD
|
|
2016-05-27 |
2016-05-25 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
3,010
-0.8%
8.80
26,480
USD
|
3,010
-0.8%
|
8.80
|
26,480
USD
|
|
2016-05-27 |
2016-05-25 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
9,012
-0.8%
8.80
79,280
USD
|
9,012
-0.8%
|
8.80
|
79,280
USD
|
|
2016-05-27 |
2016-05-25 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
12,022
-0.7%
8.80
105,760
USD
|
12,022
-0.7%
|
8.80
|
105,760
USD
|
|
2016-05-27 |
2016-05-25 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
12,022
-0.7%
8.80
105,760
USD
|
12,022
-0.7%
|
8.80
|
105,760
USD
|
|
2016-05-25 |
2016-05-24 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
150
-0.0%
8.95
1,343
USD
|
150
-0.0%
|
8.95
|
1,343
USD
|
|
2016-05-25 |
2016-05-24 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
200
-0.0%
8.95
1,790
USD
|
200
-0.0%
|
8.95
|
1,790
USD
|
|
2016-05-25 |
2016-05-24 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
200
-0.0%
8.95
1,790
USD
|
200
-0.0%
|
8.95
|
1,790
USD
|
|
2016-05-25 |
2016-05-24 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
50
-0.0%
8.95
448
USD
|
50
-0.0%
|
8.95
|
448
USD
|
|
2016-05-25 |
2016-05-23 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
900
-0.1%
9.00
8,100
USD
|
900
-0.1%
|
9.00
|
8,100
USD
|
|
2016-05-25 |
2016-05-23 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
1,200
-0.1%
9.00
10,800
USD
|
1,200
-0.1%
|
9.00
|
10,800
USD
|
|
2016-05-25 |
2016-05-23 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
1,200
-0.1%
9.00
10,800
USD
|
1,200
-0.1%
|
9.00
|
10,800
USD
|
|
2016-05-25 |
2016-05-23 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
300
-0.1%
9.00
2,700
USD
|
300
-0.1%
|
9.00
|
2,700
USD
|
|
2016-05-23 |
2016-05-20 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
11,148
-0.6%
9.08
101,210
USD
|
11,148
-0.6%
|
9.08
|
101,210
USD
|
|
2016-05-23 |
2016-05-20 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
11,148
-0.6%
9.08
101,210
USD
|
11,148
-0.6%
|
9.08
|
101,210
USD
|
|
2016-05-23 |
2016-05-20 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
2,791
-0.7%
9.08
25,339
USD
|
2,791
-0.7%
|
9.08
|
25,339
USD
|
|
2016-05-23 |
2016-05-20 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
8,357
-0.7%
9.08
75,872
USD
|
8,357
-0.7%
|
9.08
|
75,872
USD
|
|
2016-05-23 |
2016-05-19 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
5,000
-0.3%
9.12
45,595
USD
|
5,000
-0.3%
|
9.12
|
45,595
USD
|
|
2016-05-23 |
2016-05-19 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
5,000
-0.3%
9.12
45,595
USD
|
5,000
-0.3%
|
9.12
|
45,595
USD
|
|
2016-05-23 |
2016-05-19 |
S
Sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
1,252
-0.3%
9.12
11,417
USD
|
1,252
-0.3%
|
9.12
|
11,417
USD
|
|
2016-05-23 |
2016-05-19 |
S
Sale
|
SCP Vitalife Partners II LP
Large shareholder
|
3,748
-0.3%
9.12
34,178
USD
|
3,748
-0.3%
|
9.12
|
34,178
USD
|
|
2016-05-26 |
2016-04-13 |
S
Sale
|
Gricci Jodi
VP Global Marktng & Training
Officer
|
65
-2.7%
12.02
781
USD
|
65
-2.7%
|
12.02
|
781
USD
|
|
2016-05-26 |
2016-04-13 |
S
Sale
|
Hamilton John Vincent
VP, Regulatory & Clinical
Officer
|
65
-2.7%
12.02
781
USD
|
65
-2.7%
|
12.02
|
781
USD
|
|
2016-03-09 |
2016-03-07 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
3,002
-0.2%
8.33
25,007
USD
|
3,002
-0.2%
|
8.33
|
25,007
USD
|
|
2016-03-09 |
2016-03-07 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
3,002
-0.2%
8.33
25,007
USD
|
3,002
-0.2%
|
8.33
|
25,007
USD
|
|
2016-03-07 |
2016-03-04 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
1,998
-0.1%
8.50
16,983
USD
|
1,998
-0.1%
|
8.50
|
16,983
USD
|
|
2016-03-07 |
2016-03-04 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
1,998
-0.1%
8.50
16,983
USD
|
1,998
-0.1%
|
8.50
|
16,983
USD
|
|
2016-03-07 |
2016-03-03 |
S
Sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
5,001
-0.3%
8.80
44,009
USD
|
5,001
-0.3%
|
8.80
|
44,009
USD
|
|
2016-03-07 |
2016-03-03 |
S
Sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
5,001
-0.3%
8.80
44,009
USD
|
5,001
-0.3%
|
8.80
|
44,009
USD
|
|
2016-01-20 |
2016-01-15 |
PS
Planned sale
|
Dykan Jeff
Non-Executive Director
Large shareholder
|
50,000
-2.7%
10.30
514,840
USD
|
50,000
-2.7%
|
10.30
|
514,840
USD
|
|
2016-01-20 |
2016-01-15 |
PS
Planned sale
|
SCP Vitalife Partners II LP
Large shareholder
|
37,481
-3.0%
10.30
385,934
USD
|
37,481
-3.0%
|
10.30
|
385,934
USD
|
|
2016-01-20 |
2016-01-15 |
PS
Planned sale
|
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
|
12,519
-3.0%
10.30
128,906
USD
|
12,519
-3.0%
|
10.30
|
128,906
USD
|
|
2016-01-20 |
2016-01-15 |
PS
Planned sale
|
Weisman Wayne
Non-Executive Director
Large shareholder
|
50,000
-2.7%
10.30
514,840
USD
|
50,000
-2.7%
|
10.30
|
514,840
USD
|
|
2016-05-26 |
2016-01-13 |
S
Sale
|
Gricci Jodi
VP Global Marktng & Training
Officer
|
264
-9.7%
9.30
2,455
USD
|
264
-9.7%
|
9.30
|
2,455
USD
|
|
2016-05-26 |
2016-01-13 |
S
Sale
|
Hamilton John Vincent
VP, Regulatory & Clinical
Officer
|
264
-9.7%
9.30
2,455
USD
|
264
-9.7%
|
9.30
|
2,455
USD
|
|